BACKGROUNDLichen planopilaris is a frequent presentation of primary cicatricial alopecia.
Scalp distribution characterizes the main clinical presentations: classic lichen
planopilaris, frontal fibrosing alopecia and Graham-Little Piccardi-Lassueur
Syndrome (GLPLS).OBJECTIVEDescription of the clinical, dermoscopic and histopathological findings of Lichen
planopilaris in public and private practices.METHODA retrospective observational study was performed by reviewing medical records of
patients with lichen planopilaris.RESULTSEighty patients were included, 73 (91,25%) were female. Prototype II was seen in
53 (66,25%) patients. Classic lichen planopilaris was seen in 62,5% of the cases.
Frontal fibrosing alopecia was seen in 31% of the patients and only one patient
presented Graham-Little Piccardi-Lassueur Syndrome (GLPLS). Scalp lesions were
scattered throughout the scalp in 47 (58,75%) of the patients, while 24 (30%)
presented mainly central scalp lesions, 29 (36,25%) presented marginal lesions and
only 4 (5%) patents had vertex lesions.CONCLUSIONSClinical presentation of Lichen planopilaris varies. To recognize the
heterogeneity of the clinical appearance in lichen planopilaris is important for
differential diagnosis.
Erosive pustular dermatosis of the scalp is a rare inflammatory disorder of the
scalp, affecting elderly patients after local trauma and leading to scarring or
cicatricial alopecia. Case Report: An elderly female patient complained of painful
pustules on the parietal region bilaterally with progressive enlargement and
ulceration. A biopsy suggested erosive pustular dermatosis of the scalp and the
patient was treated with prednisone 40 mg/day and 0.1% topical tacrolimus. After 10
weeks complete closure of the eroded areas was observed and a stable scarring
alopecia developed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.